A 2024 poll from KFF, a nonprofit health policy research, polling and news organization, found that 1 in 8 adults say theyve taken a GLP-1 drug, and over half of adults, 61%, say Medicare should cover the drug for obese Medicare patients
As demand for weight-loss drugs rises, states grapple with Medicaid coverage Some researchers question long-term cost savings for state programs
Whether the sensorylikingwanting dissociation proposed for GLP-1RAs is maintained, strengthened, or modified under dual, triple-agonist and amylin-based co-agonist therapy remains uncertain
Trusted across the Greater Atlanta area, including Alpharetta and Cumming, GA, our team delivers compassionate, personalized care tailored to your goals